Advertisement
CVBF vs WVE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVBF is a Buy and WVE is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CVBF’s FA Score shows that 0 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).
- CVBF’s FA Score: 0 green, 5 red.
- WVE’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CVBF’s TA Score shows that 4 TA indicator(s) are bullish while WVE’s TA Score has 6 bullish TA indicator(s).
- CVBF’s TA Score: 4 bullish, 6 bearish.
- WVE’s TA Score: 6 bullish, 1 bearish.
Price Growth
CVBF (@Regional Banks) experienced а -3.78% price change this week, while WVE (@Biotechnology) price change was +9.43% for the same time period.
The average weekly price growth across all stocks in the @Regional Banks industry was -0.09%. For the same industry, the average monthly price growth was +2.33%, and the average quarterly price growth was +3.94%.
The average weekly price growth across all stocks in the @Biotechnology industry was +5.74%. For the same industry, the average monthly price growth was +2.75%, and the average quarterly price growth was +0.73%.
Reported Earning Dates
CVBF is expected to report earnings on Jul 23, 2025.
WVE is expected to report earnings on Jul 31, 2025.
Industries' Descriptions
@Regional Banks (-0.09% weekly)Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.
@Biotechnology (+5.74% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| CVBF | WVE | CVBF / WVE | |
| Capitalization | 2.49B | 1B | 248% |
| EBITDA | N/A | -117.1M | - |
| Gain YTD | -12.314 | -47.454 | 26% |
| P/E Ratio | 10.95 | N/A | - |
| Revenue | 547M | 105M | 521% |
| Total Cash | 231M | 243M | 95% |
| Total Debt | 2.07B | 23.6M | 8,771% |
CVBF | WVE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 58 | 15 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | 53 Fair valued | |
PROFIT vs RISK RATING 1..100 | 79 | 100 | |
SMR RATING 1..100 | 9 | 96 | |
PRICE GROWTH RATING 1..100 | 60 | 65 | |
P/E GROWTH RATING 1..100 | 29 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 17 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
WVE's Valuation (53) in the Biotechnology industry is in the same range as CVBF (68) in the Regional Banks industry. This means that WVE’s stock grew similarly to CVBF’s over the last 12 months.
CVBF's Profit vs Risk Rating (79) in the Regional Banks industry is in the same range as WVE (100) in the Biotechnology industry. This means that CVBF’s stock grew similarly to WVE’s over the last 12 months.
CVBF's SMR Rating (9) in the Regional Banks industry is significantly better than the same rating for WVE (96) in the Biotechnology industry. This means that CVBF’s stock grew significantly faster than WVE’s over the last 12 months.
CVBF's Price Growth Rating (60) in the Regional Banks industry is in the same range as WVE (65) in the Biotechnology industry. This means that CVBF’s stock grew similarly to WVE’s over the last 12 months.
CVBF's P/E Growth Rating (29) in the Regional Banks industry is significantly better than the same rating for WVE (100) in the Biotechnology industry. This means that CVBF’s stock grew significantly faster than WVE’s over the last 12 months.
| CVBF | WVE | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 60% | N/A |
| Stochastic ODDS (%) | 1 day ago 56% | 1 day ago 83% |
| Momentum ODDS (%) | 1 day ago 52% | 1 day ago 87% |
| MACD ODDS (%) | 1 day ago 49% | 1 day ago 77% |
| TrendWeek ODDS (%) | 1 day ago 62% | 1 day ago 80% |
| TrendMonth ODDS (%) | 1 day ago 57% | 1 day ago 86% |
| Advances ODDS (%) | 23 days ago 59% | 1 day ago 76% |
| Declines ODDS (%) | 3 days ago 59% | 9 days ago 86% |
| BollingerBands ODDS (%) | 1 day ago 65% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 50% | 1 day ago 81% |
Advertisement
CVBF and
Correlation & Price change
A.I.dvisor indicates that over the last year, CVBF has been closely correlated with HOPE. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if CVBF jumps, then HOPE could also see price increases.
| Ticker / NAME | Correlation To CVBF | 1D Price Change % | ||
|---|---|---|---|---|
| CVBF | 100% | +0.98% | ||
| HOPE - CVBF | 90% Closely correlated | +2.02% | ||
| BANR - CVBF | 90% Closely correlated | +1.27% | ||
| UBSI - CVBF | 90% Closely correlated | +1.24% | ||
| CATY - CVBF | 89% Closely correlated | +1.48% | ||
| TRMK - CVBF | 89% Closely correlated | +1.28% | ||
More | ||||
WVE and
Correlation & Price change
A.I.dvisor indicates that over the last year, WVE has been loosely correlated with PRQR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then PRQR could also see price increases.
| Ticker / NAME | Correlation To WVE | 1D Price Change % | ||
|---|---|---|---|---|
| WVE | 100% | +4.00% | ||
| PRQR - WVE | 59% Loosely correlated | N/A | ||
| KRRO - WVE | 52% Loosely correlated | +10.46% | ||
| KYMR - WVE | 44% Loosely correlated | +1.04% | ||
| ATNF - WVE | 42% Loosely correlated | -1.89% | ||
| OCUL - WVE | 42% Loosely correlated | +2.71% | ||
More | ||||